Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: A rationale for combination with radiation therapy

Radiotherapy and Oncology

Volumn 105, Issue 1, 2012, Pages 64-71

  Karroum, Oussama ^a   Kengen, Julie ^a   Danhier, Pierre ^a   Magat, Julie ^a   Mignion, Lionel ^a   Bouzin, Caroline ^a   Verrax, Julien ^a   Charette, Nicolas ^a   Starkel, Peter ^a   Calderon, Pedro Buc ^a   Sonveaux, Pierre ^a   Feron, Oliver ^a   Grégoire, Vincent ^a   Gallez, Bernard ^a   Jordan, Bénédicte F ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

MAPK; O2 consumption; Oxygenation; Radiosensitivity; Tumor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; SORAFENIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CELL ACTIVITY; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; IN VIVO STUDY; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; REOXYGENATION; TUMOR BLOOD FLOW; TUMOR REOXYGENATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; APOPTOSIS; BENZAMIDES; BLOTTING, WESTERN; DIPHENYLAMINE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FIBROSARCOMA; GLUTATHIONE; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASMS, EXPERIMENTAL; NIACINAMIDE; OXYGEN CONSUMPTION; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; RADIATION TOLERANCE;

EID: 84868354894     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.05.005     Document Type: Article

References (47)

1. 2 tension measurements Cancer Res 51 1991 3316 3322
2. P. Vaupel, D.K. Kelleher, and O. Thews Modulation of tumor oxygenation Int J Radiat Oncol Biol Phys 42 1998 843 848
3. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47
4. L. Gray, A. Conger, M. Ebert, S. Hornsey, and O.C. Scott The concentration of oxygen dissolved in tissues at time of irradiation as a factor in radiotherapy Br J Radiol 26 1953 638 648
5. Horsman MR, van der Kogel AJ. In: Joiner M, van der Kogel A, editors. Basic Clinical Radiobiology. 4th ed. London: H. Arnold; 2009. p. 233-45.
6. A. Rojas, M.C. Joiner, R.J. Hodgkiss, U. Carl, E. Kjellen, and G.D. Wilson Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys Int J Radiat Oncol Biol Phys 23 1992 361 366
7. J.L. Tatum, G.J. Kelloff, and R.J. Gillies Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy Int J Radiat Biol 82 2006 699 757
8. P. Sonveaux Provascular strategy: targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment Radiother Oncol 86 2008 300 313
9. B.F. Jordan, and B. Gallez Surrogate MR markers of response to chemo- or radiotherapy in association with co-treatments: a retrospective analysis of multi-modal studies Contrast Media Mol Imaging 5 2010 323 332
10. B.F. Jordan, N. Beghein, N. Crokart, C. Baudelet, V. Grégoire, and B. Gallez Preclinical safety and antitumor efficacy of insulin combined with irradiation Radiother Oncol 81 2006 112 117
11. E. Cohen-Jonathan, S.M. Evans, and C.J. Koch The farnesyltransferase inhibitor L744, 832 reduces hypoxia in tumors expressing activated H-ras Cancer Res 61 2001 2289 2293
12. T.B. Brunner, A.K. Gupta, and Y. Shi Farnesyltransferase inhibitors as radiation sensitizers Int J Radiat Biol 79 2003 569 576
13. C.A. Pratilas, and D.B. Solit Targeting the Mitogen-Activated Protein Kinase pathway: physiological feedback and drug response Clin Cancer Res 16 2010 3329 3334
14. S.M. Wilhelm, C. Carter, and L. Tang BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis Cancer Res 64 2004 7099 7109
15. J.S. Sebolt-Leopold, and R. Herrera Targeting the mitogen-activated protein kinase cascade to treat cancer Nat Rev Cancer 4 2004 937 947
16. 2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studies Antioxid Redox Signal 9 2007 1169 1182
17. H.M. Swartz, and R.B. Clarkson The measurement of oxygen in vivo using EPR techniques Phys Med Biol 43 1998 1957 1975
18. H.S. Taper, G.W. Woolley, M.N. Teller, and M.P. Lardis A new transplantable mouse liver tumor of spontaneous origin Cancer Res 26 1966 143 148
19. J.P. Volpe, N. Hunter, I. Basic, and L. Milas Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take Clin Exp Metastasis 3 1985 281 294
20. B. Gallez, C. Baudelet, and B.F. Jordan Assessment of tumor oxygenation by electron paramagnetic resonance. principles and applications NMR Biomed 17 2004 240 262
21. B. Gallez, B.F. Jordan, C. Baudelet, and P.D. Misson Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry Magn Reson Med 42 1999 627 630
22. G. Sersa, M. Cemazar, D. Miklavcic, and D.J. Chaplin Tumor blood flow modifying effect of electrochemotherapy with bleomycin Anticancer Res 19 1999 4017 4022
23. B.F. Jordan, V. Gregoire, and R.J. Demeure Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption Cancer Res 62 2002 3555 3561
24. P.E. James, S.K. Jackson, O.Y. Grinberg, and H.M. Swartz The effects of endotoxin on oxygen consumption of various cell types in vitro: an EPR oximetry study Free Radic Biol Med 18 1995 641 647
25. F. Tietze Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal Biochem 27 1969 502 522
26. O.W. Griffith Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine Anal Biochem 106 1980 207 212
27. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
28. N. Crokart, B.F. Jordan, and C. Baudelet Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption Clin Cancer Res 13 2007 630 635
29. R. Ansiaux, C. Baudelet, and B.F. Jordan Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy Cancer Res 66 2006 9698 9704
30. J.P. Plastaras, S.H. Kim, and Y.Y. Liu Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation Cancer Res 67 2007 9443 9454
31. A.W. Suen, S. Galoforo, and B. Marples Sorafenib and radiation: a promising combination in colorectal cancer Int J Radiat Oncol Biol Phys 78 2010 213 220
32. B.A. Teicher, S.A. Holden, and G. Ara Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy Int J Cancer 61 1995 732 737
33. B.A. Teicher, N. Dupuis, and T. Kusomoto Anti-angiogenic agents can increase tumor oxygenation and response to radiation therapy Radiat Oncol Investig 2 1994 269 276
34. C. Lee, M. Heijn, and E. Di Tomaso Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 2000 5565 5570
35. R. Ansiaux, C. Baudelet, and B.F. Jordan Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy Cancer Res 66 2006 9698 9704
36. R. Ansiaux, J. Dewever, V. Gregoire, O. Feron, B.F. Jordan, and B. Gallez Decrease in tumor cell oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and its effect on response to radiotherapy Radiat Res 172 2009 584 591
37. J.E. Biaglow, Y. Manevich, and D. Leeper MIBG inhibits respiration: potential for radio- and hyperthermic sensitization Int J Radiat Oncol Biol Phys 1 1998 871 876
38. P. Guha, A. Dey, R. Sen, M. Chatterjee, S. Chattopadhyay, and S.K. Bandyopadhyay Intracellular GSH depletion triggered mitochondrial bax translocation to accomplish resveratrol-induced apoptosis in the U937 cell line J Pharmacol Exp Ther 336 2011 206 214
39. J.F. Chiou, C.J. Tai, Y.H. Wang, T.Z. Liu, Y.M. Jen, and C.Y. Shiau Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant Hep G2 cells through a mitochondria-dependent oxidative stress mechanism Cancer Biol Ther 8 2009 1904 1913
40. D. Strumberg, H. Richly, and R.A. Hilger Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors J Clin Oncol 23 2005 965 972
41. M. Rahmani, E.M. Davis, C. Bauer, P. Dent, and S. Grant Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation J Biol Chem 280 2005 35217 35227
42. S. Huber, M. Oelsner, and T. Decker Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1 Leukemia 25 2011 838 847
43. S. Carloni, F. Fabbri, and G. Brigliadori Tyrosine Kinase inhibitors Gefitinib, Lapatinib and Sorafenib induce rapid functional alterations in breast cancer cells Curr Cancer Drug Targets 10 2010 422 431
44. Y. Pignochino, G. Grignani, and G. Cavalloni Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways Mol Cancer 8 2009 118
45. Q. Ding, L. Huo, and J.Y. Yang Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer Cancer Res 68 2008 6109 6117
46. R.K. Jain Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy Nat Med 7 2001 987 989
47. Rakesh.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science. 307 2005 58 62